Poulvac® Ovoline® CVI
Modified live frozen vaccine against highly pathogenic Marek's disease, serotype 1 (Rispens CVI)
Live frozen vaccine, serotype 1 (Rispens CVI)
Against highly pathogenic Marek's disease — day-old chicks or in ovo
In ovo (18–19 days) or subcutaneous injection
Available as
Frozen vaccine
For use with
Poultry (chickens)
Strength
Live Marek's disease virus serotype 1 (Rispens CVI)
How it is supplied
5 × 2,000 doses
Drug description
Live Vaccine POULVAC® OVOLINE® CVI
Poulvac® Ovoline® CVI is a modified live frozen vaccine. Composition: Marek's disease vaccine, serotype 1 (Rispens CVI), live frozen virus.
Demonstrated efficacy for vaccination of healthy day-old chicks or in ovo vaccination of 18–19-day embryonated chicken eggs against highly pathogenic Marek's disease.
Route of administration: in ovo or subcutaneous injection. Packaging: 5 × 2,000 doses.
Contact us
Start cooperation with industry leaders
